The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced successful results of the Patient Advocates for Lupus Studies (PALS) pilot study that were published in ACR Open Rheumatology.

The study showed that 12 months after finishing the PALS program, participants’ knowledge about lupus clinical trials had increased significantly, and nearly half had taken some action toward joining a trial.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release